Clinical Trials List
Protocol NumberYO28405
2014-04-01 - 2018-12-19
Phase III
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林璟宏 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 郭文宏 Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of Radiology
- 金光亮 Division of General Surgery
- 王國鐘 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Principal Investigator
Co-Principal Investigator
- Chi-Chang Yu Division of General Surgery
- 沈士哲 Division of General Surgery
- 張潤忠 Division of Radiology
- Yung-Chang Lin Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
- Shin-Cheh Chen Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
757 participants
